Biotech Values

[mskatiescarletohara]

++++I have studied all of the facts at hand with regard to Squalamine's potential and its safety and there is actually NO REASON to assume as of yet that the drug carries a safety concern!

What datum do you base this on and wouldn't you agree your view on the data is SPECULATORY? Afterall, small cap biotechs are speculative in nature.

If you think delivering Squalamine as a systemic IS NOT a safety concern with the current mindset at the FDA then you have not done your homework. I would like for you present to the board what subjective evidence you have reviewed to determine Squalamine doesn't have any safety issues when administered. Do you have access to follow up care from Mexico and the current patients in Phase II?

Thanks,

katie...